Hartford, United States
Gate Science, Inc., established in 2020, is making strides in the pharmaceutical industry by introducing RELAY, an innovative solution designed to control postoperative pain for up to 28 days, targeting the pain management gap following surgery. Unlike current non-opioid treatments limited to providing relief for 3 days, RELAY aims to reduce the dependency on opioids, crucially addressing "The Therapeutic Gap".
The company's slogan, "Introducing the first SINGLE SOLUTION designed to safely control pain for up to 28 days after surgery", emphasizes its pioneering approach. The device uses a combination of Nerve Block and Neurostimulation, allowing patients to modulate pain relief through a smartphone app, Gate Keeper.
With a focused entry into the 18 million annual orthopedic surgeries in the United States, the co-founders bring notable experience from six prior ventures and nine product launches. Although the RELAY device awaits FDA clearance, the firm's $1.05M early-stage backing on 28 April 2021 highlights investor confidence in its potential.